Journal
JOURNAL OF NEUROIMMUNOLOGY
Volume 132, Issue 1-2, Pages 113-116Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0165-5728(02)00316-8
Keywords
prion protein; DnaK; transmissible encephalopathies; Hsp70 as immunological adjuvant; vaccination; autoantibodies
Categories
Ask authors/readers for more resources
The causative and infectious agent of the transmissible spongiform encephalopathies, e.g. bovine spongiform encephalopathy in cattle or variant Creutzfeldt-Jakob disease in humans, is a pathogenic form of the scrapie prion protein (PrPSc) generated by a conformational rearrangement in the normal cellular prion protein (PrPC). Anti-PrP antibodies have been shown to exert a protective effect against infection with PrPSc. However, the generation of anti-PrP antibodies has proven quite difficult in wild-type animals, PrP being a notoriously poor immumogen. We developed a vaccine against PrP by mixing recombinant murine PrP 23-231 with DnaK, an Hsp70 homolog in Escherichia coli, and cross-linking the two proteins by means of glutaraldehyde. After three injections of the vaccine into BALB/c mice at 6, 8 and 9 weeks of age, a low-titer immune response was detected with ELISA in all animals. The specificity of the antibodies for PrP was confirmed with Western blotting. The straightforward procedure might render active immunization against prion infection feasible. (C) 2002 Elsevier Science B.V All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available